The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2019 | Recent developments in radiotherapy for lung cancer
Françoise Mornex, MD, PhD, of Claude Bernard University, Lyon, France, discusses recent developments in radiotherapy techniques for lung cancer, including intensity-modulated radiotherapy (IMRT) and stereotactic radiotherapy. Speaking at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland, Prof. Mornex reports that IMRT is especially promising as the method allows the delivery of optimal doses of radiation to the tumor while sparing other, healthy organs.
